Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print July 2, 2008, doi:10.1212/01.wnl.0000312378.94737.45)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
01.wnl.0000312378.94737.45v1
01.wnl.0000312378.94737.45v2
71/12/876    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Sabatelli, M.
Right arrow Articles by Tonali, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sabatelli, M.
Right arrow Articles by Tonali, P.
Related Collections
Right arrow Prognosis
Right arrow Amyotrophic lateral sclerosis
Right arrow Natural history studies (prognosis)
NEUROLOGY 2008;71:876-881
© 2008 American Academy of Neurology

Natural history of young-adult amyotrophic lateral sclerosis

M. Sabatelli, MD, F. Madia, MD, A. Conte, MD, M. Luigetti, MD, M. Zollino, MD, I. Mancuso, PhD, M. Lo Monaco, MD, G. Lippi, MD and P. Tonali, MD

From Istituto di Neurologia (M.S., F.M., A.C., M.L., M.L.M., P.T.); Istituto di Genetica Medica (M.Z., I.M.), Università Cattolica del Sacro Cuore; and UILDM sez. Laziale (G.L.), Rome, Italy; and Fondazione Don Gnocchi (P.T.), Milan, Italy.

Address correspondence and reprint requests to Dr. Mario Sabatelli, Istituto di Neurologia. Pol. "A: Gemelli", Largo Gemelli, 8, 00168 Rome, Italy msabatelli{at}rm.unicatt.it

Background: Amyotrophic lateral sclerosis (ALS) affects people of all ages, but whether the wide range of age at onset is due to distinct diseases or merely reflects phenotypic variability of the same disorder is still unknown. The purpose of this study is to describe clinical and prognostic features of young-adult ALS, with onset before age 40 years, and to compare them with features of the common adult-onset type.

Methods: We analyzed clinical features and long-term follow-up of 57 young-adult ALS patients, with disease onset between 20 and 40 years, and compared them with 450 patients affected by adult-onset ALS.

Results: We found that the majority of young-adult patients showed a predominant upper motor neuron (p-UMN) ALS, characterized by marked spastic paraparesis, with lower motor neuron signs confined to the upper limbs. The proportion of patients with p-UMN ALS phenotype was 59.6% in the young-adult patients and 17.4% in the adult-onset form (p < 0.0001). Young-adult ALS with p-UMN phenotype had longer survival than did the classic phenotype: median survival was 74 months (range 10–226, 95% CI 60.61–87.38) in the former and 56 months (range 6–106, 95% CI 48.65–63.34) in the latter (p = 0.03). In the young-adult patients, a marked male excess was observed in the p-UMN ALS group (5.8:1), whereas the ratio of men to women was 1.1:1 in the classic phenotype (p = 0.01).

Conclusions: Our findings show that young-adult amyotrophic lateral sclerosis with the predominant upper motor neuron phenotype represents a distinctive clinical variant characterized by a unique clinical pattern, longer survival, and male prevalence.

Abbreviations: ALS = amyotrophic lateral sclerosis; p-UMN = predominant upper motor neuron.


Editorial, page 872.

e-Pub ahead of print on July 2, 2008, at www.neurology.org.

Supported by Fondazione Roma and by the Association for ALS research I.CO.M.M., Onlus, Rome, Italy.

Disclosure: The authors report no disclosures.

Received November 7, 2007. Accepted in final form February 6, 2008.




This article has been cited by other articles:


Home page
NeurologyHome page
C. Armon
From clues to mechanisms: Understanding ALS initiation and spread
Neurology, September 16, 2008; 71(12): 872 - 873.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by AAN Enterprises, Inc.